Healthcare Health/Fitness

Actelion's Shareholders Veto Compensation Plan

Riding high on the UBS backlash, Actelion investors reject plan for executive compensation during shareholder meeting.


Additional Funding for Allecra Therapeutics

Allecra Therapeutics raise new funding. Edmond de Rothschild Investment Partners disclosed to the public the primary investment of BioDiscovery 4 through its participation in the Series A financing round of Allerca Therapeutics.

Calpers City Member Quits Fund

In an unprecedented move, Canyon Lake City has opted out and terminated its contract with Calpers. Canyon Lake is home to Calpers, the largest public pension fund in the US with US$256 billion in assets.

Carlyle and Palamon Partner to Acquire DBG Ltd

Carlyle and Palamon acquires DBG Ltd from Synova Capital. Global asset manager The Carlyle Group in conjunction with Palamon Capital Partners have announced the acquisition of DBG Limited from Synova Capital.


Latest News

Springfield Homecare, using the Business Growth Fund, purchases Positive Life Choices. Springfield Homecare Services Ltd is a unit of Springfield Healthcare Group, which is backed by the Business Growth Fund.
Dr Stella M. Sung has been appointed as the new COO for Tauriga Sciences. In an announcement, biotechnology company Tauriga Sciences has named Stella M.
Panasonic of Japan is selling part of its shareholdings in its healthcare unit for expansion plans. Panasonic Corp of Japan has engaged the services of Bank of America Merrill Lynch in order to sell a part of its healthcare subsidiary, The deal could raise as much as US$1 billion for the electronics company, according to two sources familiar with the transaction who spoke on condition of anonymity.
Agila Biotech and Pfenex Inc enter into a joint venture for development of multiple sclerosis drug development.
Dysis Medical closes latest funding round at US$11 million. DySiS Medical Ltd was able to complete GBP7. 4 Million or US$11 million on a round of capital infusion.
An IPO is to be made of shares of Portola Pharmaceuticals expecting a return of US$150 million. An application to offer through initial public offering shares of stock from Portola Pharmaceuticals has been filed with regulatory authorities.
Public pension fund Birmingham Retirement & Relief System has sued SAC Capital Advisors LP over allegations of insider trading.
Syros Pharmaceuticals gets US$30 million financing through a Series A round with institutional investors.
Biodesix raises fund through preferred shares sales. The molecular diagnostic company, Biodesix Inc, has added US$8. 8 million funding through another round of sales of its preferred shares in Series D funding round.
Lippo Group would undertake three separate IPOs for its units. One of the leading Indonesian conglomerates, Lippo Group, is aiming to make US$300 million for IPOs of its banking, healthcare and information technology units.
  74 75 76 77 78 79 80 81 82  
Real Time Analytics